ArticlePharmaceutics2019

LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats.

Seung Yon Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.